Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...
SOME diseases are so devastating that survival is virtually impossible – with fatality rates hitting 100 per cent. Thankfully, due to modern medicine, they’re incredibly rare. The few that ...